3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with hexamethonium in 1 studies
Studies (3-(2,4-dimethoxybenzylidene)anabaseine) | Trials (3-(2,4-dimethoxybenzylidene)anabaseine) | Recent Studies (post-2010) (3-(2,4-dimethoxybenzylidene)anabaseine) | Studies (hexamethonium) | Trials (hexamethonium) | Recent Studies (post-2010) (hexamethonium) |
---|---|---|---|---|---|
166 | 8 | 81 | 2,287 | 3 | 129 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akaike, A; Kihara, T; Kimura, J; Kochiyama, H; Kume, T; Maeda, T; Sawada, H; Shimohama, S | 1 |
1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and hexamethonium
Article | Year |
---|---|
Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity.
Topics: Amyloid beta-Peptides; Animals; Benzylidene Compounds; Bungarotoxins; Cell Death; Cell Survival; Cells, Cultured; Cerebral Cortex; Fetus; Hexamethonium; Mecamylamine; Neurons; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Peptide Fragments; Pyridines; Rats; Receptors, Nicotinic | 1997 |